Laboratory purchasing decisions are often framed around the price of a single unit, which is usually the least informative number available. In reagent categories where material is sold in varying vial sizes and varying concentrations, the headline price tells you very little about what an experiment will actually cost.
The Per-Milligram View
The first correction most purchasing groups make is switching from cost per vial to cost per milligram. A ten milligram vial at one hundred and fifty dollars works out to fifteen dollars per milligram. A five milligram vial at ninety dollars works out to eighteen. Same compound, same category, materially different unit economics — and the smaller vial looks cheaper on the shelf.
This is not a trick so much as an artefact of how the market lists product. Vial sizes vary between suppliers, and price is displayed per vial because that is the unit being sold. Converting to a common denominator takes seconds and changes the ranking more often than not.
Why the Larger Vial Is Not Always Better
Per-milligram pricing improves with vial size, but the calculation has a second term: waste. Peptides degrade after reconstitution, and a large vial reconstituted for a small experiment may lose material to time before it is used.
Freeze-thaw cycling compounds this. Lyophilised material is comparatively stable stored at minus twenty degrees Celsius or below, protected from light. Once in solution, stability drops considerably, and repeated warming and refreezing degrades material further. Aliquoting into single-use volumes at reconstitution mitigates the problem but does not eliminate it.
The practical rule is that the optimal vial size depends on experimental cadence rather than on price alone. Groups running frequent work extract the volume discount. Groups running occasional work often pay more per usable milligram buying large.
The Content Correction
There is a further adjustment most buyers never make. Lyophilised preparations include residual water and counter-ions from synthesis, so a vial labelled at a given weight may contain less actual peptide than that figure implies.
Peptide content by weight — a measurement reported on complete certificates of analysis and omitted from incomplete ones — is what converts a label weight into a usable number. Without it, cost per milligram is cost per milligram of unspecified material. Two suppliers can differ by fifteen percent on content alone, which is larger than most of the price differences buyers agonise over.
Comparing Across Suppliers
Because vial sizes, concentrations, and reported content all vary, cross-supplier comparison is genuinely tedious. Resources that track tesamorelin cost across vendors and normalise for vial size do that arithmetic in advance, which is useful when the alternative is building a spreadsheet from a dozen product pages.
Regulatory Context
Research peptides are laboratory materials designated for research use only. They are not approved for human or veterinary use, and not intended for diagnostic or therapeutic application. Suppliers framing them in terms of personal outcomes are operating outside the research market entirely.
The Summary
Convert everything to cost per milligram before comparing. Adjust for peptide content where the certificate reports it. Size vials to experimental cadence rather than to the volume discount. And treat the certificate of analysis as a budgeting document rather than a compliance formality — it contains the numbers that make the comparison real.
